Last month, drug company Genentech reported on the first clinical trials of the drug crenezumab, a drug targeting amyloid proteins that form sticky plaques in the brains of Alzheimer’s disease patients. The drug had been particularly effective in...
You must log in or register to comment.
Subscribe to see new publications and popular science coverage of current research on your homepage
- 0 users online
- 7 users / day
- 19 users / week
- 34 users / month
- 107 users / 6 months
- 8 subscribers
- 1.04K Posts
- 1.11K Comments
- Modlog
- mods:
- @MinutePhrase@lemmy.ml
Damn thats insane. I remember hearing about the study and it being a big step in medical field. How did nobody peer reviewing it look at the images and compare them. Shows a broken system